Austria-based diabetes app company mySugr has raised $4.8 million from Roche Ventures and iSeed Ventures. Existing investor XLHealth also contributed to the round, which will help mySugr scale up its user base in the US and other other countries. iSeed Ventures is a new fund that has only made a half dozen investments so far, and it is led by former iHealth Lab head Adam Lin.
MySugr offers a...
Israel-based HelpAround, which makes an app that connects people with diabetes in the same immediate area, has raised $550,000 from Windham Venture Partners and angel investors Walter Winshall, Robert Oringer and former Harmonix COO Michael Dornbrook. Windham and the angel investors co-led the round.
MobiHealthNews wrote about HelpAround earlier this year at HIMSS, where the company positioned...
Diabetes app maker mySugr, which is based in Austria and the US, raised a few million euros in an investment round led by XL Health and Puspok. Johann Hansmann, an angel investor that has previously invested in Runtastic, also participated. mySugr had previously raised another round from Hansmann and Austria's state owned investment bank, AWS.
mySugr's app recently topped 100,000 registered users...
Israel-based LabStyle Innovations, which is developing a smartphone-based glucose meter, has raised $10 million by common stock that the company plans to accredited investors. The company plans to use the money to develop, market and manufacture Dario, its smartphone-enabled diabetes management system. Dario does not have a CE mark nor does it have FDA approval. LabStyle CEO Dr. Oren Fuerst aims...
A recent meta-analysis from The Cochrane Library found that computer-based interventions for Type 2 diabetes provide, at best, a small improvement from traditional care methods. The analysis, based on 16 studies, found that the interventions reduced A1C (the standard measure for blood glucose control) by 0.2 percent, although that rose to 0.5 percent for mobile-based interventions. Measures of...
Bethesda, Maryland-based Telcare, which offers an FDA cleared cellular-enabled glucose monitor and its cloud-based companion system, has scooped up $25.5 million in funding led by new backer Sequoia Capital with participation from its existing investor Qualcomm Life Fund. Telcare will use the funds to build out its marketing, sales, research and development. Telcare had previously raised about $4...
Glooko, a mobile diabetes management startup, inked a deal with Roche Diabetes Care to extend the Glooko MeterSync to ACCU-CHEK meter users via an infrared data transfer adapter. The Glooko IR Adapter helps iPhone or iPod touch users who would like to more easily download blood glucose readings from their ACCU-CHEK meters to the Glooko Logbook app on their iOS device. The infrared adapter works...
Senior care company Independa has inked a deal with Telcare to add its cellular-enabled glucose meter to its remote management services for older people. Telcare's meter received clearance from the FDA last August, making it the first meter with cellular embedded.
The Telcare BGM device sends the glucose readings to the company's central server, which then sends it to Independa's cloud-based...
This week Telcare, makers of an FDA-cleared, cellular-enabled blood glucose meter, launched a free, companion iPhone app, called MyTelcare Diabetes Pal that helps Telcare BGM users to track their glucose readings, medications, nutrition, activities and more. The app automatically receives glucose readings from the TelcareBGM device, which means no more manual logging of blood glucose readings....
Glooko, which offers a simple glucose monitoring logbook app and a cable that connects meters to iPhones, recently raised $3.5 million in its first round of funding, which was led by The Social+Capital Partnership, and included return backers Bill Campbell, Vint Cerf, Judy Estrin and Andy Hertzfeld, Venky Harinarayan, Russell Hirsch and Xtreme Labs, according to various reports. The Social+...
